• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRKL 过表达与非小细胞肺癌不良预后和细胞增殖相关。

Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.

机构信息

Department of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, China.

出版信息

Mol Carcinog. 2013 Nov;52(11):890-9. doi: 10.1002/mc.21935. Epub 2012 Jun 29.

DOI:10.1002/mc.21935
PMID:22753141
Abstract

Crk-Like (CRKL) is an adapter protein that has crucial roles in multiple biological processes, including cell proliferation, adhesion, and migration. Amplification of CRKL gene was found in non-small cell lung cancer (NSCLC). However, the expression pattern of CRKL protein and its clinical significance in human NSCLC have not been well characterized to date. In this study, expression of CRKL was evaluated in 131 NSCLC tissues by immumohistochemistry. CRKL protein was up-regulated in the lung carcinomas compared with adjacent normal lung tissue. Overexpression of CRKL was found in 58 of 131 (44.3%) NSCLC samples and correlated with poor tumor differentiation (P = 0.0042), histological type (adenocarcinoma; P = 0.001), advanced p-TNM stage (P = 0.0004), nodal metastasis (P = 0.0273), high proliferation index (P = 0.0062) and poor overall survival (P = 0.0084). Further univariate and multivariate analysis showed a significant association of CRKL overexpression and worse overall survival in lung cancer patients. In addition, overexpression of CRKL in HBE and H1299 cell lines promoted cell proliferation by facilitating cell cycle progression. Further analysis of cell cycle related molecules showed that CRKL induced cyclin D1, cyclin B1 expression, and increased Rb phosphorylation. In conclusion, this study demonstrated overexpression of CRKL correlated with poor prognosis and lung cancer proliferation by cell cycle regulation.

摘要

Crk 样蛋白(CRKL)是一种衔接蛋白,在多种生物学过程中发挥着关键作用,包括细胞增殖、黏附和迁移。非小细胞肺癌(NSCLC)中发现 CRKL 基因扩增。然而,迄今为止,CRKL 蛋白在人类 NSCLC 中的表达模式及其临床意义尚未得到充分描述。在这项研究中,通过免疫组织化学评估了 131 例 NSCLC 组织中 CRKL 的表达。与相邻正常肺组织相比,肺癌中 CRKL 蛋白呈上调表达。在 131 例 NSCLC 样本中,发现 58 例(44.3%)存在 CRKL 过表达,且与肿瘤分化差(P=0.0042)、组织学类型(腺癌;P=0.001)、晚期 p-TNM 分期(P=0.0004)、淋巴结转移(P=0.0273)、高增殖指数(P=0.0062)和总生存不良(P=0.0084)相关。进一步的单因素和多因素分析显示,CRKL 过表达与肺癌患者总生存不良显著相关。此外,在 HBE 和 H1299 细胞系中过表达 CRKL 通过促进细胞周期进程促进细胞增殖。对细胞周期相关分子的进一步分析表明,CRKL 诱导 cyclin D1、cyclin B1 表达,并增加 Rb 磷酸化。总之,本研究表明,CRKL 过表达与不良预后和肺癌增殖有关,其机制与细胞周期调控有关。

相似文献

1
Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.CRKL 过表达与非小细胞肺癌不良预后和细胞增殖相关。
Mol Carcinog. 2013 Nov;52(11):890-9. doi: 10.1002/mc.21935. Epub 2012 Jun 29.
2
Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer.SPAG9 过表达在非小细胞肺癌中的临床意义和生物学作用。
Lung Cancer. 2013 Aug;81(2):266-72. doi: 10.1016/j.lungcan.2013.04.021. Epub 2013 May 24.
3
Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.CRKL的过表达与乳腺癌中的恶性细胞增殖相关。
Tumour Biol. 2013 Oct;34(5):2891-7. doi: 10.1007/s13277-013-0851-7. Epub 2013 May 19.
4
Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.Rb、p16(INK4A)和细胞周期蛋白D1在非小细胞肺癌中的表达变化及其临床意义。
J Pathol. 1999 Aug;188(4):351-60. doi: 10.1002/(SICI)1096-9896(199908)188:4<351::AID-PATH385>3.0.CO;2-W.
5
[Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].[非小细胞肺癌组织中核因子-κB活性及其与细胞增殖的相关性]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Oct;30(10):771-5.
6
Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.Cyclin D2 表达降低与 III 期非小细胞肺癌的无复发生存不良独立相关,而与 cyclin D1 无关。
Lung Cancer. 2012 Aug;77(2):401-6. doi: 10.1016/j.lungcan.2012.03.027. Epub 2012 Apr 24.
7
Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.Derlin-1 在非小细胞肺癌中过表达,并通过 EGFR-ERK 介导的 MMP-2 和 MMP-9 的上调促进癌细胞侵袭。
Am J Pathol. 2013 Mar;182(3):954-64. doi: 10.1016/j.ajpath.2012.11.019. Epub 2013 Jan 7.
8
[Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].[AKT2、细胞周期蛋白D1和基质金属蛋白酶-9的表达及其与非小细胞肺癌临床病理特征的相关性]
Ai Zheng. 2006 Jan;25(1):69-72.
9
Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.细胞周期蛋白B1和细胞周期蛋白A在非小细胞肺癌中的表达及预后意义
Histopathology. 2009 Jul;55(1):28-36. doi: 10.1111/j.1365-2559.2009.03331.x.
10
miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.miRNA-214 与人类非小细胞肺癌的侵袭性有关,并直接调节蛋白激酶 2 的表达。
Genes Chromosomes Cancer. 2013 Oct;52(10):895-911. doi: 10.1002/gcc.22085. Epub 2013 Aug 9.

引用本文的文献

1
MicroRNA-939 induces apoptosis in human liver cancer cells by targeting CRKL expression.微小RNA-939通过靶向CRKL表达诱导人肝癌细胞凋亡。
Arch Med Sci. 2020 Apr 15;21(3):991-998. doi: 10.5114/aoms.2020.94437. eCollection 2025.
2
The p130Cas-Crk/CrkL Axis: A Therapeutic Target for Invasive Cancers Unveiled by Collaboration Among p130Cas, Crk, and CrkL.p130Cas-Crk/CrkL轴:p130Cas、Crk和CrkL合作揭示的侵袭性癌症治疗靶点
Int J Mol Sci. 2025 Apr 24;26(9):4017. doi: 10.3390/ijms26094017.
3
Comprehensive DNA methylation profiling by MeDIP-NGS identifies potential genes and pathways for epithelial ovarian cancer.
基于 MeDIP-NGS 的全基因组 DNA 甲基化分析鉴定上皮性卵巢癌的潜在基因和通路。
J Ovarian Res. 2024 Apr 16;17(1):83. doi: 10.1186/s13048-024-01395-3.
4
Genetic alterations of GI-NECs involving three main signaling pathways.涉及三条主要信号通路的 GI-NEC 遗传改变。
Cancer Med. 2023 Apr;12(7):8238-8250. doi: 10.1002/cam4.5633. Epub 2023 Jan 18.
5
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.针对EML4-ALK驱动的肺癌,ALK抑制剂单药治疗的替代治疗方案
Cancers (Basel). 2022 Jul 15;14(14):3452. doi: 10.3390/cancers14143452.
6
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.在单中心治疗的一组血管肉瘤患者中,免疫检查点阻断治疗反应的临床、基因组和转录组相关性。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-004149.
7
Crk and CrkL as Therapeutic Targets for Cancer Treatment.Crk 和 CrkL 作为癌症治疗的治疗靶点。
Cells. 2021 Mar 27;10(4):739. doi: 10.3390/cells10040739.
8
Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.定量评估体外脑胶质瘤表型可将细胞迁移作为 Crk 和 CrkL 活性的可靠读出。
J Biol Chem. 2021 Jan-Jun;296:100390. doi: 10.1016/j.jbc.2021.100390. Epub 2021 Feb 6.
9
Increased Soluble CrkL in Serum of Breast Cancer Patients Is Associated with Advanced Disease.乳腺癌患者血清中可溶性CrkL增加与疾病进展相关。
Cancers (Basel). 2019 Jul 9;11(7):961. doi: 10.3390/cancers11070961.
10
MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).微小 RNA-379 通过直接靶向 V-crk 禽肉瘤病毒 CT10 癌基因同源物(CRKL)抑制宫颈癌细胞的增殖和侵袭。
Oncol Res. 2018 Aug 23;26(7):987-996. doi: 10.3727/096504017X15140534417184. Epub 2018 Jan 2.